Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Gains from Investment Securities: 2011-2025

Historic Gains from Investment Securities for ProPhase Labs (PRPH) over the last 8 years, with Sep 2025 value amounting to $185,000.

  • ProPhase Labs' Gains from Investment Securities was N/A to $185,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2024, which is 34.88% down from last year.
  • ProPhase Labs' Gains from Investment Securities amounted to $185,000 in Q3 2025, which was up 362.50% from $40,000 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Gains from Investment Securities ranged from a high of $6.0 million in Q4 2022 and a low of -$392,000 during Q4 2023.
  • Over the past 3 years, ProPhase Labs' median Gains from Investment Securities value was $287,000 (recorded in 2024), while the average stood at $1.2 million.
  • In the last 5 years, ProPhase Labs' Gains from Investment Securities plummeted by 3,172.73% in 2022 and then soared by 1,594.17% in 2023.
  • ProPhase Labs' Gains from Investment Securities (Quarterly) stood at $290,000 in 2021, then soared by 934.48% to $6.0 million in 2022, then slumped by 106.53% to -$392,000 in 2023, then surged by 845.66% to $2.9 million in 2024, then decreased by 19.50% to $185,000 in 2025.
  • Its Gains from Investment Securities stands at $185,000 for Q3 2025, versus $40,000 for Q2 2025 and $256,000 for Q1 2025.